Catalyst Pharmaceuticals Stock Market Value
| CPRX Stock | USD 15.34 0.66 4.13% |
| Symbol | Catalyst |
Catalyst Pharmaceuticals Price To Book Ratio
Is Catalyst Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalyst Pharmaceuticals. If investors know Catalyst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalyst Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.346 | Earnings Share 0.63 | Revenue Per Share 3.747 | Quarterly Revenue Growth 0.82 | Return On Assets 0.1283 |
The market value of Catalyst Pharmaceuticals is measured differently than its book value, which is the value of Catalyst that is recorded on the company's balance sheet. Investors also form their own opinion of Catalyst Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Catalyst Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalyst Pharmaceuticals' market value can be influenced by many factors that don't directly affect Catalyst Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalyst Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Catalyst Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalyst Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Catalyst Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Catalyst Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Catalyst Pharmaceuticals.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Catalyst Pharmaceuticals on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Catalyst Pharmaceuticals or generate 0.0% return on investment in Catalyst Pharmaceuticals over 30 days. Catalyst Pharmaceuticals is related to or competes with Pmv PharmaceuticalsI, and Molecular Partners. Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing ... More
Catalyst Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Catalyst Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Catalyst Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.59 | |||
| Information Ratio | 0.0248 | |||
| Maximum Drawdown | 15.45 | |||
| Value At Risk | (3.73) | |||
| Potential Upside | 4.05 |
Catalyst Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Catalyst Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Catalyst Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Catalyst Pharmaceuticals historical prices to predict the future Catalyst Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0389 | |||
| Jensen Alpha | 0.0096 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0256 | |||
| Treynor Ratio | 0.0635 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Catalyst Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Catalyst Pharmaceuticals Backtested Returns
We consider Catalyst Pharmaceuticals not too volatile. Catalyst Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0204, which signifies that the company had a 0.0204% return per unit of risk over the last 3 months. We have found thirty technical indicators for Catalyst Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Catalyst Pharmaceuticals' Mean Deviation of 2.04, downside deviation of 2.59, and Risk Adjusted Performance of 0.0389 to double-check if the risk estimate we provide is consistent with the expected return of 0.0547%. Catalyst Pharmaceuticals has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.97, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Catalyst Pharmaceuticals will likely underperform. Catalyst Pharmaceuticals right now shows a risk of 2.68%. Please confirm Catalyst Pharmaceuticals potential upside, as well as the relationship between the accumulation distribution and price action indicator , to decide if Catalyst Pharmaceuticals will be following its price patterns.
Auto-correlation | -0.4 |
Poor reverse predictability
Catalyst Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Catalyst Pharmaceuticals time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Catalyst Pharmaceuticals price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Catalyst Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Catalyst Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Catalyst Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Catalyst Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Catalyst Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Catalyst Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Catalyst Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Catalyst Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Catalyst Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Catalyst Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Catalyst Pharmaceuticals Lagged Returns
When evaluating Catalyst Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Catalyst Pharmaceuticals stock have on its future price. Catalyst Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Catalyst Pharmaceuticals autocorrelation shows the relationship between Catalyst Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Catalyst Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Catalyst Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Catalyst Stock
| 0.69 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Catalyst Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Pharmaceuticals to buy it.
The correlation of Catalyst Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Catalyst Pharmaceuticals Correlation, Catalyst Pharmaceuticals Volatility and Catalyst Pharmaceuticals Alpha and Beta module to complement your research on Catalyst Pharmaceuticals. For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Catalyst Stock analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Catalyst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.